pharma · Allergies · Early Parkinson Disease
Advanced Accelerator Applications
Advanced Accelerator Applications clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON
- Employees
- 590
- Programs
- 12
- Drugs
- 25
- Patents
- 25
Advanced Accelerator Applications projects
3 ClinicalTrials.gov programs sponsored by Advanced Accelerator Applications.
Advanced Accelerator Applications has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ODYSSEY
Advanced Accelerator Applications
Patients with Relapsed/Refractory Acute Myeloid Leukemia or High/Very-high Risk Myelodysplastic Syndromes, Ineligible for Intensiveor New Generation Targeted Therapy
1 trial -
SPARC1210
Advanced Accelerator Applications
Breast Cancer
1 trial -
SPARC1613
Advanced Accelerator Applications
Recurrent or Metastatic Breast Cancer
1 trial
Frequently asked questions
How many clinical projects does Advanced Accelerator Applications have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.